Back
Biomea Fusion Vs. Phathom Pharmaceuticals Industry Stock Comparison
Sell
37
BMEA
Biomea Fusion
Last Price:
7.09
Seasonality Move:
-24.73%
Buy
65
PHAT
Phathom Pharmaceuticals
Last Price:
17.75
Seasonality Move:
-12.97%
Sell
37
Biomea Fusion (BMEA)
is a Sell
Is Biomea Fusion a Buy, Sell or Hold?
- The current Biomea Fusion [BMEA] share price is $7.05. The Score for BMEA is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- BMEA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $17.70. The Score for PHAT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BMEA Stock Price Chart
What is Biomea Fusion's stock price today?
-
The Biomea Fusion share price today is $7.05
The current trend is moderately bullish and BMEA is experiencing selling pressure, which indicates risk of future bearish movement.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $17.70
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing slight buying pressure.
BMEA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.46 | Buy |
| Relative Strength Index (14 RSI): | 55.33 | Buy |
| Chaikin Money Flow: | -263064 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.68 - 7.4) | Buy |
| Bollinger Bands (100): | (4.85 - 10.71) | Sell |
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.52 | Buy |
| Relative Strength Index (14 RSI): | 78.65 | Buy |
| Chaikin Money Flow: | 2385 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.49 - 15.93) | Buy |
| Bollinger Bands (100): | (9.42 - 13.26) | Buy |
BMEA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.49 | Sell |
| 20-day SMA: | 6.72 | Buy |
| 50-day SMA: | 5.81 | Buy |
| 200-day SMA: | 11.6 | Sell |
| 8-day EMA: | 7.32 | Sell |
| 20-day EMA: | 6.89 | Buy |
| 50-day EMA: | 6.73 | Buy |
| 200-day EMA: | 10.44 | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.71 | Buy |
| 20-day SMA: | 14.34 | Buy |
| 50-day SMA: | 12.47 | Buy |
| 200-day SMA: | 9.99 | Buy |
| 8-day EMA: | 16.55 | Buy |
| 20-day EMA: | 14.89 | Buy |
| 50-day EMA: | 13.1 | Buy |
| 200-day EMA: | 11.05 | Buy |
Biomea Fusion Earnings Growth & BMEA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.08 per share, a decrease this year of $0.52 per share, and an increase next year of $0.40 per share.
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.50 per share, an increase next quarter of $0.54 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Biomea Fusion Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Phathom Pharmaceuticals Technical Analysis
| Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 23 | 26 | 27 | 28 | 29 | 30 | 03 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||